# NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria

> **NCT01547897** · PHASE2 · COMPLETED · sponsor: **TME Pharma AG** · enrollment: 76 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Albuminuria

## Interventions

- **DRUG:** NOX-E36

## Key facts

- **NCT ID:** NCT01547897
- **Lead sponsor:** TME Pharma AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-09
- **Final completion:** 2013-12
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2014-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01547897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01547897, "NOX-E36 in Patients With Type 2 Diabetes Mellitus and Albuminuria". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01547897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*